AI assistant
GILEAD SCIENCES, INC. — Director's Dealing 2017
Mar 3, 2017
29828_dirs_2017-03-03_0e6268d3-b6bc-45ef-a409-4ace0df38631.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2017-03-01
Reporting Person: MOORE NICHOLAS G (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-03-01 | Common Stock | M | 173 | — | Acquired | 12055 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-03-01 | Phantom Stock | $0 | M | 173 | Disposed | Common Stock (173) | Direct |
Footnotes
F1: Each share of phantom stock is the economic equivalent of one share of Gilead common stock, except fractional shares are paid in cash.
F2: An aggregate of 173.167681 shares were reported in Table II when reporting person acquired the phantom shares. The fractional share of 0.167681 was paid out in cash in connection with the conversion into shares of common stock.
F3: The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.